3.8 Article

The Role of Transforming Growth Factor beta 1 in the Regulation of Blood Pressure

Journal

CURRENT HYPERTENSION REVIEWS
Volume 10, Issue 4, Pages 223-238

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157340211004150319123313

Keywords

Corticosteroid; collecting duct; epithelial sodium channel; endothelin; nitric oxide

Funding

  1. National Institutes of Health Grants [DK76131, HL49277]
  2. Juvenile Diabetes Research Foundation [2006-2-106]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007750, U01DK076131] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Although human association studies suggest a link between polymorphisms in the gene encoding transforming growth factor (TGF) beta 1 and differing blood pressure levels, a causative mechanism for this correlation remains elusive. Recently we have generated a series of mice with graded expression of TGF beta 1, ranging from approximately 10% to 300% compared to normal. We have found that blood pressure and plasma volume are negatively regulated by TGF beta 1. Of note, the 10% hypomorph exhibits primary aldosteronism and markedly impaired urinary excretion of water and electrolytes. We here review previous literature highlighting the importance of TGF beta signaling as a natriuretic system, which we postulate is a causative mechanism explaining how polymorphisms in TGF beta 1 could influence blood pressure levels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available